Antiarrhythmic	antiarrhythmic	O	O
effects	effects	O	O
of	of	O	O
optical	optical	O	O
isomers	isomers	O	O
of	of	O	O
cibenzoline	cibenzoline	O	O
on	on	O	O
canine	canine	O	O
ventricular	ventricular	O	O
arrhythmias	arrhythmias	O	O
.	.	O	O

Antiarrhythmic	antiarrhythmic	O	O
effects	effects	O	O
of	of	O	O
(+)-cibenzoline	(+)-cibenzoline	O	O
and	and	O	O
(-)-cibenzoline	(-)-cibenzoline	O	O
were	were	O	O
examined	examined	O	O
using	using	O	O
two	two	O	O
canine	canine	O	O
ventricular	ventricular	O	O
arrhythmia	arrhythmia	O	S_disease
models	models	O	O
.	.	O	O

Digitalis	digitalis	O	O
arrhythmia	arrhythmia	O	S_disease
,	,	O	O
which	which	O	O
is	is	O	O
suppressed	suppressed	O	O
by	by	O	O
Na	na	O	O
channel	channel	B_chemicals	O
blockers	blockers	I_chemicals	O
,	,	O	O
was	was	O	O
induced	induced	O	O
by	by	O	O
intermittent	intermittent	O	O
intravenous	intravenous	O	O
(	(	O	O
i.v	i.v	O	O
.	.	O	O
)	)	O	O
injection	injection	O	O
of	of	O	O
ouabain	ouabain	S_chemicals	O
in	in	O	O
pentobarbital-anesthetized	pentobarbital-anesthetized	O	O
dogs	dogs	O	O
.	.	O	O

Adrenaline	adrenaline	S_chemicals	O
arrhythmia	arrhythmia	O	S_disease
,	,	O	O
which	which	O	O
is	is	O	O
suppressed	suppressed	O	O
by	by	O	O
Ca	ca	O	O
channel	channel	B_chemicals	O
blockers	blockers	I_chemicals	O
,	,	O	O
was	was	O	O
induced	induced	O	O
by	by	O	O
adrenaline	adrenaline	S_chemicals	O
infusion	infusion	O	O
in	in	O	O
halothane-anesthetized	halothane-anesthetized	O	O
dogs	dogs	O	O
.	.	O	O

Ten	ten	O	O
and	and	O	O
5	5	O	O
mg/kg	mg/kg	O	O
i.v	i.v	O	O
.	.	O	O

(+)-cibenzoline	(+)-cibenzoline	O	O
suppressed	suppressed	O	O
digitalis-	digitalis-	O	O
and	and	O	O
adrenaline-induced	adrenaline-induced	O	O
arrhythmias	arrhythmias	O	O
,	,	O	O
respectively	respectively	O	O
.	.	O	O

The	the	O	O
minimum	minimum	O	O
effective	effective	O	O
plasma	plasma	O	O
concentrations	concentrations	O	O
of	of	O	O
(+)-cibenzoline	(+)-cibenzoline	O	O
for	for	O	O
digitalis-	digitalis-	O	O
and	and	O	O
adrenaline-induced	adrenaline-induced	O	O
arrhythmias	arrhythmias	O	O
were	were	O	O
1.4	1.4	O	O
+	+	O	O
/-	/-	O	O
0.4	0.4	O	O
and	and	O	O
2.0	2.0	O	O
+	+	O	O
/-	/-	O	O
0.6	0.6	O	O
micrograms/ml	micrograms/ml	O	O
,	,	O	O
respectively	respectively	O	O
(	(	O	O
mean	mean	O	O
+	+	O	O
/-	/-	O	O
SD	sd	O	O
,	,	O	O
n	n	O	O
=	=	O	O
6	6	O	O
)	)	O	O
.	.	O	O

A	a	O	O
lower	lower	O	O
dose	dose	O	O
of	of	O	O
1	1	O	O
mg/kg	mg/kg	O	O
i.v	i.v	O	O
.	.	O	O
of	of	O	O
(-)-cibenzoline	(-)-cibenzoline	O	O
suppressed	suppressed	O	O
the	the	O	O
digitalis-induced	digitalis-induced	O	O
arrhythmia	arrhythmia	O	S_disease
,	,	O	O
whereas	whereas	O	O
5	5	O	O
mg/kg	mg/kg	O	O
i.v	i.v	O	O
.	.	O	O
was	was	O	O
needed	needed	O	O
to	to	O	O
suppress	suppress	O	O
adrenaline-induced	adrenaline-induced	O	O
arrhythmias	arrhythmias	O	O
.	.	O	O

The	the	O	O
minimum	minimum	O	O
effective	effective	O	O
plasma	plasma	O	O
concentrations	concentrations	O	O
of	of	O	O
(-)-cibenzoline	(-)-cibenzoline	O	O
for	for	O	O
digitalis-	digitalis-	O	O
and	and	O	O
adrenaline-induced	adrenaline-induced	O	O
arrhythmia	arrhythmia	O	S_disease
were	were	O	O
0.06	0.06	O	O
+	+	O	O
/-	/-	O	O
0.04	0.04	O	O
and	and	O	O
0.7	0.7	O	O
+	+	O	O
/-	/-	O	O
0.1	0.1	O	O
micrograms/ml	micrograms/ml	O	O
,	,	O	O
respectively	respectively	O	O
(	(	O	O
mean	mean	O	O
+	+	O	O
/-	/-	O	O
SD	sd	O	O
,	,	O	O
n	n	O	O
=	=	O	O
6	6	O	O
)	)	O	O
.	.	O	O

The	the	O	O
stronger	stronger	O	O
antiarrhythmic	antiarrhythmic	O	O
effect	effect	O	O
of	of	O	O
(-)-cibenzoline	(-)-cibenzoline	O	O
indicates	indicates	O	O
that	that	O	O
(-)-isomer	(-)-isomer	S_chemicals	O
may	may	O	O
have	have	O	O
an	an	O	O
effect	effect	O	O
nearly	nearly	O	O
5	5	O	O
-	-	O	O
20	20	O	O
times	times	O	O
stronger	stronger	O	O
in	in	O	O
suppressing	suppressing	O	O
Na	na	O	O
channels	channels	O	O
,	,	O	O
but	but	O	O
effects	effects	O	O
of	of	O	O
both	both	O	O
drugs	drugs	S_chemicals	O
on	on	O	O
Ca	ca	O	O
channels	channels	O	O
may	may	O	O
be	be	O	O
almost	almost	O	O
equipotent	equipotent	O	O
.	.	O	O

